N-methylcarbamate insecticide residues, including carbamate metabolites, are extracted with methanol. The extract is cleaned up by partitioning and column chromatography on a charcoal/Celite column. Residues are selectively determined
1 Codes: C: complete (>80%); P: partial (50-80%); S: small (<50%); V: variable (approximate percentage when known); R: recovered but no quantitative information available; NR: not recovered
Use of any multiresidue method (MRM) is supported by available information about how potential residues behave through the steps of the method. To provide that support for PAM I MRMs, additional chemicals are continually tested through the method steps and the resulting data compiled in a single database. All PAM
Multiresidue methodology by definition requires determinative steps capable of separating analytes from one another so each can be detected and measured individually. Both gas-liquid chromatography (GLC) and high performance liquid
In recent years, high performance liquid chromatography (HPLC) has grown in popularity as a determinative step for residue analysis, until today it is accepted as complementary to the more traditional gas liquid
10.1 Federal Regulation of Medical Devices 10.1.1 The Law (including amendments) 10.1.2 Organization of FDA 10.1.3 Classification of Devices 10.1.4 Process of Assessment 10.1.4.1 510(k)Substantial Equivalence 10.1.4.2 Premarket Approval 10.1.5 Clinical Trials (Investigational Device Exemption) 10.1.6 Labeling 10.1.7 Tripartite Biocompatibility Guidance 10.1.8 Standards 10.1.9 Good Manufacturing Procedures 10.1.10 Good Laboratory Practices 10.2 Clinical Trial Design
